These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 4517716)
1. Transfer of transplantation immunity with RNA. Likhite V Ann N Y Acad Sci; 1973 May; 207():389-97. PubMed ID: 4517716 [No Abstract] [Full Text] [Related]
2. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953 [No Abstract] [Full Text] [Related]
3. In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA. Vyas GN; Ibrahim AB; Rao KR; Likhite V Nature; 1974 Feb; 247(5440):377-8. PubMed ID: 4817858 [No Abstract] [Full Text] [Related]
4. Lymphoid RNA in antibody formation. Immunogenic RNA during immunity and tolerance. Friedman H Ann N Y Acad Sci; 1973 May; 207():178-99. PubMed ID: 4126320 [No Abstract] [Full Text] [Related]
5. The role of RNA in cell-mediated immunity. Mitsuhashi S; Saito K; Kurashige S; Osawa N; Kitamura K Ann N Y Acad Sci; 1973 May; 207():380-8. PubMed ID: 4517715 [No Abstract] [Full Text] [Related]
6. Cell-mediated tumor allograft immunity: in vitro transfer with RNA. Likhite V; Sehon A Science; 1972 Jan; 175(4018):204-5. PubMed ID: 5008442 [TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity after allogeneic transplantation in the rat. IV. The effect of heterologous antilymphocyte serum on cellular and humoral immunity after allogeneic renal transplantation. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplantation; 1973 Nov; 16(5):441-50. PubMed ID: 4584954 [No Abstract] [Full Text] [Related]
8. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors. Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952 [No Abstract] [Full Text] [Related]
9. Failure of passive transfer of homograft sensitivity in mice by means of extracts of sensitised lymphoid cells. Warren J; Gowland G J Med Microbiol; 1969 Aug; 2(3):279-85. PubMed ID: 4932019 [No Abstract] [Full Text] [Related]
10. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor. Nakashima Y Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561 [No Abstract] [Full Text] [Related]
11. A model for immunity to melanomas in mice. Burger DR; Hu F; Pasztor LM; Malley A Proc Soc Exp Biol Med; 1973 Nov; 144(2):426-30. PubMed ID: 4746912 [No Abstract] [Full Text] [Related]
12. RNA-mediated transfer of tumor immunity--a new model for the immunotherapy of cancer. Deckers PJ; Pilch YH Cancer; 1971 Nov; 28(5):1219-28. PubMed ID: 5125669 [No Abstract] [Full Text] [Related]
13. Transfer of cell-mediated immunity by immune RNA assessed by migration-inhibition. Thor DE Ann N Y Acad Sci; 1973 May; 207():355-68. PubMed ID: 4517714 [No Abstract] [Full Text] [Related]
14. [RNA and its role in transferred immunity]. Antonenko VT; Lisniak IA Fiziol Zh; 1977; 23(6):840-6. PubMed ID: 338373 [No Abstract] [Full Text] [Related]
15. Migration inhibition and homograft rejection in rats. Eidemiller LR; Bell PR Transplantation; 1972 Jan; 13(1):5-8. PubMed ID: 4550350 [No Abstract] [Full Text] [Related]
16. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma. Dvorák R; Lindner J Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435 [No Abstract] [Full Text] [Related]
17. Antigen-induced refractory period of adoptive transfer. Rose NR; Twarog FJ Transplant Proc; 1969 Mar; 1(1):564-6. PubMed ID: 5408711 [No Abstract] [Full Text] [Related]
18. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA. Deckers PJ; Pilch YH Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197 [No Abstract] [Full Text] [Related]
19. Resistance and susceptibility to tumours. V. On the permeation of the 3H thymidine labelled cells from lymphatic organs into the site of proliferating tumour. Dvorák R; Lindner J Neoplasma; 1971; 18(1):41-62. PubMed ID: 5575434 [No Abstract] [Full Text] [Related]
20. Tumor inhibition by means of sensitized regional lymph nodes. Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M Surg Forum; 1969; 20():114-5. PubMed ID: 5383023 [No Abstract] [Full Text] [Related] [Next] [New Search]